Johnson & Johnson

Johnson & Johnson as of March 31, 2025

Portfolio Holdings for Johnson & Johnson

Johnson & Johnson holds 20 positions in its portfolio as reported in the March 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Protagonist Therapeutics (PTGX) 34.6 $118M 2.4M 48.36
CVRX (CVRX) 14.7 $50M 4.1M 12.23
Meiragtx Holdings (MGTX) 13.2 $45M 6.6M 6.78
Legend Biotech Corporation Sponsored Ads (LEGN) 8.1 $28M 815k 33.93
Rapport Therapeutics (RAPP) 7.3 $25M 2.5M 10.03
Procept Biorobotics Corp (PRCT) 6.1 $21M 358k 58.26
Nanobiotix Sponsored Ads (NBTX) 5.9 $20M 5.6M 3.58
Contineum Therapeutics Cl A (CTNM) 4.0 $14M 2.0M 6.98
Xencor (XNCR) 2.3 $8.0M 748k 10.64
Arrowhead Pharmaceuticals (ARWR) 0.9 $3.2M 248k 12.74
Fate Therapeutics (FATE) 0.8 $2.7M 3.4M 0.79
Rallybio Corp (RLYB) 0.7 $2.4M 3.6M 0.65
Neumora Therapeutics (NMRA) 0.5 $1.8M 1.8M 1.00
Nano-X Imaging Ord Shs (NNOX) 0.2 $794k 159k 5.00
Vor Biopharma (VOR) 0.2 $771k 1.1M 0.72
Lyell Immunopharma 0.1 $443k 823k 0.54
D Fluidigm Corp Del (LAB) 0.1 $337k 312k 1.08
Adicet Bio (ACET) 0.1 $275k 365k 0.76
Chardan Healthcare Acqu- Ord 0.0 $54k 97k 0.56
Senseonics Hldgs (SENS) 0.0 $36k 55k 0.66